← Insider buys
KRTX

Karuna Therapeutics, Inc.

Director Atul Pande sold $250K of Karuna Therapeutics, Inc.

Sold$250,000
$100.00Price
2,500Shares
−100%Stake

What KRTX did after the filing

Prices for KRTX after this filing aren't in yet.

Traded Mon, Feb 1. Filed Mon, Feb 1, 4:23 PM ET, after the close. Not investment advice.